Nexgel (NXGL) Common Equity (2018 - 2025)

Nexgel (NXGL) has 8 years of Common Equity data on file, last reported at $4.5 million in Q4 2025.

• For the quarter ending Q4 2025, Common Equity fell 22.52% year-over-year to $4.5 million; the trailing twelve-month figure through Dec 2025 stood at $4.5 million (down 22.52% YoY), and the FY2025 full-year result was $4.5 million, down 22.52% from the prior year.
• Common Equity for Q4 2025 stood at $4.5 million, down from $5.6 million in the prior quarter.
• Across five years, Common Equity topped out at $12.1 million in Q4 2021 and bottomed at $270000.0 in Q2 2021.
• The 5-year median for Common Equity is $5.6 million (2025), against an average of $5.8 million.
• Peak annual rise in Common Equity reached 16921.13% in 2021, while the deepest fall reached 38.78% in 2021.
• A 5-year view of Common Equity shows it stood at $12.1 million in 2021, then plunged by 36.81% to $7.6 million in 2022, then slumped by 32.36% to $5.2 million in 2023, then advanced by 11.4% to $5.8 million in 2024, then retreated by 22.52% to $4.5 million in 2025.
• The last three Common Equity figures came in at $4.5 million (Q4 2025), $5.6 million (Q3 2025), and $5.1 million (Q2 2025), per Business Quant data.

Peer Comparison